Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Participants must be between the age of 18 and 50 years as degenerative cervical diseases are common among people over the age of 50 and this limits the possibility of degenerative changes in the participant • Present with active myofascial trigger points, unilateral or bilateral, of the upper trapezius muscle (Trp1 and Trp2). • The diagnostic criteria of TrPs on examination are: - A palpable, taut band present in a muscle - Pain elicited by digital pressure - A characteristic pattern of referred pain specific to individual muscles - The occurrence of a LTR as a result of needle insertion - Limited stretch range of motion • Must be able to attend all treatments • Participants cannot be on anti-inflammatories or other drugs which might alter their pain during the study
Exclusion criteria
Exclusion criteria: • Contra-indicated for Myofascial decompression therapy • Contra-indicated for myofascial dry needling • Received any form of treatment which may interfere with the results of the study such as massage therapy, physiotherapy, medications in the form of analgesics or anti-inflammatories. • Have no active myofascial trigger point in the upper trapezius muscle
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The result of this study may offer clarity on which treatment approach might be more beneficial for this particular condition. It will hopefully offer a better understanding of which treatment group had the most beneficial results and might aid as a guide for future management of upper trapezius myofascial trigger points. | — |
Secondary
| Measure | Time frame |
|---|---|
| MFD if as effective as myofascial dry needling could be a superior treatment approach as it is not as invasive and might be more comfortable. | — |
Countries
South Africa
Contacts
Student